Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

5. Accounts Receivable (Tables)

12 Months Ended

Mar. 31, 2018

	March 31,
	2018			2017
Accounts receivable	$	2,829,000		$	2,794,000
Less: allowance for doubtful accounts		(17,000	)		(14,000	)
Less: discounts, rebates, distributor fees and returns		(1,275,000	)		(672,000	)
	$	1,537,000		$	2,108,000